MEMBRANE TRAFFIC IN PEPTIDE HORMONE SECRETING CELLS
肽激素分泌细胞中的膜运输
基本信息
- 批准号:3232346
- 负责人:
- 金额:$ 11.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-04-01 至 1991-03-31
- 项目状态:已结题
- 来源:
- 关键词:adrenocorticotropic hormone antibody formation antibody specificity cell cell interaction chemical structure function chromosome deletion cyclic AMP endonuclease gene expression genetic manipulation high performance liquid chromatography immunofluorescence technique immunoprecipitation insulin laboratory mouse laboratory rabbit laboratory rat membrane permeability membrane proteins monoclonal antibody mutagens nucleic acid hybridization pancreatic islet function peptide hormone peptide hormone biosynthesis proinsulin protein transport proteolysis radioimmunoassay radiotracer secretion surface antigens
项目摘要
A pituitary tumor cell line (AcT-20) from the mouse packages mature ACTH
into secretory vesicles but also leaks the longer precursor form,
proopiomelanocortin (POMC) into the medium by a non-regulated or
constitutive pathway. Human proinsulin, human growth hormone and rat
trypsinogen, encoded by transfected DNA also take two pathways to the
surface but other proteins such as the endogenous laminin or the truncated
viral G protein, encoded by transfected DNA, only exit constitutively.
Since the truncated viral G protein can be targeted to the secretory
vesicle by fusing it with human growth hormone, we propose that peptide
hormones, and trypsinogen, share a common sorting domain responsible for
correct targeting to the secretory vesicle. To identify such domains we
plan to delete by oligonucleotide mutagenesis candidate domains from rat
trypsinogen, taking advantage of the known three-dimensional structure of
rat trypsinogen and other proteases. To examine the properties of the
constitutive pathway, DNA encoding immunoglobulin light and heavy chains
will be transfected into AtT-20 cells. Since immunoglobulins must assemble
before secretion, we hope to gain insight into rules of protein assembly
that will facilitate the engineering of proteins capable of secretion by
mammalian cells. The immediate goal is to link fragments of peptide
hormone to immunoglobulin chains, and re-direct them to secretory vesicles.
To allow us to begin a molecular explanation of protein secretion we have
developed an AtT-20 variant into the cytoplasm of which macromolecules can
be delivered with high efficiency using red blood cell fusion. Antibodies
to vesicle and cytoskeletal components will be introduced to try to inhibit
secretory vesicle formation, and vesicle movement to the cell surface.
Evidence that secretory vesicles show a selective association with
cytoskeletal elements will be sought. The ability to study secretory
vesicle movement, secretory vesicle formation and exocytosis in a cell line
that can be readily transfected with appropriate expression vectors, and
whose cytoplasm can be readily modified by red blood cell microinjection
gives an unusually rich opportunity to study the nature of protein
secretion and its disorders.
来自小鼠的垂体肿瘤细胞系 (AcT-20) 包装成熟的 ACTH
进入分泌囊泡,但也泄漏出较长的前体形式,
阿黑皮质素原 (POMC) 通过非调节或
构成途径。 人胰岛素原、人生长激素和大鼠
由转染 DNA 编码的胰蛋白酶原也通过两条途径到达
表面但其他蛋白质,如内源性层粘连蛋白或截短的
由转染DNA编码的病毒G蛋白仅以组成型形式存在。
由于截短的病毒 G 蛋白可以靶向分泌
通过将其与人类生长激素融合来形成囊泡,我们提出肽
激素和胰蛋白酶原共享一个共同的排序域,负责
正确靶向分泌囊泡。 为了识别此类域,我们
计划通过寡核苷酸诱变从大鼠中删除候选结构域
胰蛋白酶原,利用已知的三维结构
大鼠胰蛋白酶原和其他蛋白酶。 要检查的属性
组成型途径,编码免疫球蛋白轻链和重链的 DNA
将转染至 AtT-20 细胞中。 由于免疫球蛋白必须组装
在分泌之前,我们希望深入了解蛋白质组装的规则
这将有助于工程化能够分泌的蛋白质
哺乳动物细胞。 当前的目标是连接肽片段
激素到免疫球蛋白链,并将它们重新定向到分泌囊泡。
为了让我们开始对蛋白质分泌进行分子解释,我们有
将AtT-20变体开发到细胞质中,其大分子可以
使用红细胞融合进行高效递送。 抗体
将引入囊泡和细胞骨架成分以试图抑制
分泌囊泡的形成和囊泡运动到细胞表面。
有证据表明分泌囊泡与
将寻找细胞骨架元素。 研究分泌的能力
细胞系中的囊泡运动、分泌囊泡形成和胞吐作用
可以很容易地用适当的表达载体转染,并且
其细胞质可以通过红细胞显微注射轻松修饰
为研究蛋白质的性质提供了异常丰富的机会
分泌及其紊乱。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
REGIS B KELLY其他文献
REGIS B KELLY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('REGIS B KELLY', 18)}}的其他基金
Enhancement of UCSF Human Subjects Protection Program
加强加州大学旧金山分校人类受试者保护计划
- 批准号:
6591996 - 财政年份:2002
- 资助金额:
$ 11.33万 - 项目类别:
GORDON CONFERENCE ON THE CELL BIOLOGY OF THE NEURON
神经元细胞生物学戈登会议
- 批准号:
2054802 - 财政年份:1994
- 资助金额:
$ 11.33万 - 项目类别:
MEMBRANE TRAFFIC IN PEPTIDE HORMONE SECRETING CELLS
肽激素分泌细胞中的膜运输
- 批准号:
3232348 - 财政年份:1992
- 资助金额:
$ 11.33万 - 项目类别:
MEMBRANE TRAFFIC IN PEPTIDE HORMONE SECRETING CELLS
肽激素分泌细胞中的膜运输
- 批准号:
3232343 - 财政年份:1992
- 资助金额:
$ 11.33万 - 项目类别:
MEMBRANE TRAFFIC IN PEPTIDE HORMONE SECRETING CELLS
肽激素分泌细胞中的膜运输
- 批准号:
2139186 - 财政年份:1992
- 资助金额:
$ 11.33万 - 项目类别:
MEMBRANE TRAFFIC IN PEPTIDE HORMONE SECRETING CELLS
肽激素分泌细胞中的膜运输
- 批准号:
2139185 - 财政年份:1992
- 资助金额:
$ 11.33万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 11.33万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 11.33万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 11.33万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 11.33万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 11.33万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 11.33万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 11.33万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 11.33万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 11.33万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 11.33万 - 项目类别:














{{item.name}}会员




